Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carvedilol for the Prevention of Minor Cardiac Damage and Cardiac Function in Duchenne Muscular Dystrophy

NCT00606775 is registered in ClinicalTrials.gov with Suzuka Hospital as lead sponsor.

NCT NCT00606775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00606775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carvedilol for the Prevention of Minor Cardiac Damage and Cardiac Function in Duchenne Muscular Dystrophy
Lead sponsor
Suzuka Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2007
Completion date
December 31, 2012
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathies, duchenne muscular dystrophy